Short communication · 30 Jan 2024
Conference abstractPublished 16 Oct 2017
STVNa, A promising medicine for cardiac protection
Guangdong University of Technology, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cardiac ischemia or hypertrophy involves multiple mechanisms and may lead to heart failure. Few medicines are now available for effective treatment. STVNa, derived from Stevia, has been shown beneficial effects in protection of acute cardiac ischemia. Our recent studies demonstrated that in animals with chronically coronary occlusion, consecutive oral treatment of STVNa significantly ameliorated the deterioration of cardiac function with reduced area of infarction and apoptosis. Long-term treatment of STVNa in Transverse Aortic Constriction (TAC) rats also protected the heart from fibrosis and hypertrophy remodeling and improved both cardiac systolic and diastolic function. In isoproterenol treated ventricular myocytes, STVNa reduced hypertrophy, inhibited the increases in cytosol calcium or ROS, and preserved contractility and mitochondrial membrane potential. Proteomic analysis, cell biochemistry and electrophysiological studies indicated that STVNa protected the heart against fibrosis and remodeling of metabolite and electrophysiology during ischemia and/or reperfusion injury or hypertrophy.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 5 Jul 2018
Fimasartan protect cardiac myocyte damage in ischemic heart diseases
Conference abstract · 22 May 2017
Brain protection by adiabatic CO2 expansion for out of hospital cardiac arrest and stroke on animal models and first fortuitous clinical case
Conference abstract · 2017
First Case of Brain Protection in Out of Hospital Cardiac Arrest
Article · 2016
Thymoquinone protects against hypothyroidism-induced cardiac histopathological changes in rats through a nitric oxide/antioxidant mechanism.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectCardiology
- BylineArticles whose byline prints “Wen Tan”
